Celyad   Report issue

For profit Phase 1 Phase 3
Founded: Mont-saint-guibert Belgium (2007)

Organization Overview

First Clinical Trial
2008
NCT00810238
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Celyad (formerly named Cardio3 BioSciences) | Celyad Oncology SA | Celyad SA